By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Mesoblast Limited 

Level 1, 843A Glenhuntly Road

Caulfield South  VIC  3162  Australia
Phone: 03-9618-7000 Fax:


SEARCH JOBS


Industry
Biotechnology






Company News
National Institutes of Health (NIH) And Mesoblast Limited (MSB.AX) Enter Into Agreement for 120-Patient Trial In End-Stage Heart Failure 8/7/2014 7:37:11 AM
Positive Spinal Disc Repair Trial Results Using Mesoblast Limited (MSB.AX) Adult Stem Cells 1/30/2014 7:02:47 AM
Mesoblast Limited (MSB.AX) Reports Positive Type 2 Diabetes Trial Results 12/4/2013 7:12:15 AM
FDA Clears Commencement of Phase 3 Chronic Heart Failure Trial Using Mesoblast Limited (MSB.AX)'s Proprietary Cells 10/31/2013 10:22:34 AM
Mesoblast Limited (MSB.AX) Updates Market on Registration Plans for GVHD Cell Product in Japan 10/28/2013 9:52:53 AM
Mesoblast Limited (MSB.AX), Intrexon Corporation and ZIOPHARM Oncology, Inc. (ZIOP.OB) to Target Cancers 10/23/2013 10:03:13 AM
Mesoblast Limited (MSB.AX) Snags Osiris Therapeutics, Inc. (OSIR)'s Stem Cell Assets for Up to $100 Million 10/11/2013 7:27:59 AM
Mesoblast Limited's Phase 2 Trial For Lumbar Spinal Fusion Selected For Presentation at Premier Spine Conference 9/19/2013 9:41:16 AM
Mesoblast Limited's Strong Cash Position Enables Execution of Late-Stage Clinical Trials 8/29/2013 9:57:51 AM
Mesoblast Limited Receives $4.3 Million From Australian Government for Adult Stem Cell Pipeline Development 7/18/2013 9:23:17 AM
12345678910...
//-->